Oklahoma Surgicare Selects ProVation Medical Software for Procedure Documentation and Coding
ProVation MD, available for the full range of ASC specialties, replaces dictation and transcription and allows physicians to efficiently document procedures at the point of care. ProVation software produces complete, coding-ready and image-enhanced procedure notes that result in greater efficiency, increased profitability and clinician satisfaction.
Located in Oklahoma City, Okla., Oklahoma Surgicare is a seven-bed ASC performing a wide range of surgical procedures including ENT, gynecology, ophthalmology, oral surgery, orthopedics, pediatrics, podiatry and urology. It is Oklahoma State–certified and accredited by the Accreditation Association for Ambulatory Health Care (AAAHC).
“Oklahoma Surgicare is dedicated to providing high quality, cost-effective outpatient and short stay surgery in a friendly, patient-oriented environment,” said Arvind Subramanian, President and CEO, Wolters Kluwer Health Clinical Solutions. “We are pleased that they have selected ProVation MD for GI to further this mission and provide streamlined documentation and coding at the point of care.”
Wolters Kluwer Health’s Clinical Solutions business unit provides evidence-based medical content, workflow based applications software and services that allow clinicians to efficiently and effectively diagnose and document patient care. Key brands ProVation Medical, UpToDate®, Medi-Span®, Facts & Comparisons®, Pharmacy OneSource® and Medicom (China) lead in market segments that include drug information, disease information, clinical patient order sets, clinical documentation and hospital pharmacy productivity applications.
About ProVation Medical
ProVation® Medical is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2010 annual revenues of €3.6 billion ($4.7 billion).
Comments (0)